You just read:

Preclinical Data Presented At AACR Indicate Pacritinib's Potential To Eradicate Therapy-Resistant Leukemia Stem Cells Residing In Bone Marrow Microenvironment

News provided by

CTI BioPharma Corp.

Apr 20, 2016, 01:30 ET